SATURDAY, OCTOBER 1, 2016

Growth in maternal-child health funding outpaces disease spending

Funding assistance allocated for improving the health of mothers and children in low- and middle-income nations has grown more rapidly over the past six years than has funding for diseases such as HIV, tuberculosis and malaria. Read More »

Researchers investigate vaccine options for common diseases

Researchers at the University of Washington and the University of Texas at Galveston are exploring the ways receptor sites in cells bind to disease and vaccine particles. Read More »

Yale researchers receive grant for typhoid fever vaccine

The Yale School of Public Health recently received funds from the Bill & Melinda Gates Foundation that will help scientists continue their research for a typhoid fever vaccine. Read More »

New leaders join Malaria No More

New leaders recently joined the board of directors at the Malaria No More organization. Read More »

Heroes of Polio Eradication honored in Abu Dhabi

Abu Dhabi recently hosted the Heroes of Polio Eradication (HOPE) Awards, which honored five individuals for their work in the fight against polio. Read More »

Increased Ebola funding contributes to declines in other disease research

The eighth annual G-FINDER report shows that the worldwide investment funding Ebola research has resulted in a decline in efforts to create vaccines, drugs and diagnostics for other diseases that kill over 6 million people worldwide each year. Read More »

TB vaccine candidate trial begins in South Africa

The Infectious Disease Research Institute (IDRI) and Wellcome Trust announced that they have started the Phase 2a trial of a tuberculosis (TB) vaccine candidate in South Africa. Read More »

TB vaccine candidate trial begins in South Africa

The Infectious Disease Research Institute (IDRI) and Wellcome Trust recently announced that the organizations have started Phase 2a trial of a tuberculosis (TB) vaccine candidate in South Africa. Read More »

West Nile virus death confirmed in Washington state

The state of Washington recently confirmed its first resident to die from West Nile virus for 2015. Read More »

CMC Biologics, PATH partner to speed monoclonal antibodies development

CMC Biologics, a worldwide leader in commercial and clinical development and contract manufacturer of therapeutic proteins, recently announced a new agreement with PATH Malaria Vaccine Initiative (MVI) to create and produce malaria-specific monoclonal antibodies against malaria infections. Read More »

Washington's Salmonella outbreak increases to 90 cases

The recent outbreak of Salmonella infections, which may be connected to pork products, has now spread to 90 cases throughout Washington State. Read More »

HIV vaccine progress made

Two new studies published in PLOS Pathogens on July 9 suggest that neutralizing antibodies (Nabs) may help scientists to develop a vaccine for HIV. Read More »

I-STAR Technology may identify effective therapies against Ebola

A recent announcement states that Theraclone Science Inc., a company specializing in therapeutic antibody discovery and development, has created I-STAR Technology to identify possible therapeutic antibodies to fight against Ebola. Read More »

Seattle BioMed announces rebranding

Seattle BioMed announced yesterday that the organization has rebranded as the Center for Infectious Disease Research. Read More »

PAML and Axela partner for diseases preventable with vaccines

Pathology Associates Medical Laboratories (PAML) said Monday it is partnering with Axela, Inc. to create multiplex assays that will emphasize the immune status for diseases that are preventable with vaccines. Read More »

Whooping cough cases continue to climb in Washington state

Health officials encouraging residents to get Tdap vaccine to prevent disease Read More »

Kineta vaccine adjuvants improve vaccine protection

Representatives from Kineta, Inc., a biotechnology company that creates immune modulating drugs to treat infectious diseases, recently released data that proves Kineta’s vaccine adjuvants improve the level of protection provided by the vaccine. Read More »

Kineta's adjuvants enhance efficiency of flu vaccine

Kineta Inc., a biotechnology company focused on the development of immune modulating drugs for infectious diseases, released new data on Thursday that shows its vaccine adjuvants are increasing the defense of influenza vaccines in animal models. Read More »

Cancer drugs may treat malaria parasites

Researchers recently published the details of a study that suggests cancer drugs may successfully treat the parasites that cause malaria. Read More »

New tool for studying relapsing malaria infections

Human-chimeric mouse model used to grow livers for additional research of parasite behind disease. Read More »